CSBR vs DASH · P/E 16, rev $56.9M vs P/E 76, rev $13.72B
Champions Oncology Inc (CSBR) versus DoorDash, Inc. Class A Common Stock (DASH) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Not investment advice. Open the CSBR and DASH stock pages for the full models.
Not investment advice.